These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 30796273)
1. A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma. Zuo S; Zhang X; Wang L Sci Rep; 2019 Feb; 9(1):2615. PubMed ID: 30796273 [TBL] [Abstract][Full Text] [Related]
2. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma. Prasad B; Tian Y; Li X Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483 [TBL] [Abstract][Full Text] [Related]
3. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients. Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma. Bi Y; Wu ZH; Cao F BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019 [TBL] [Abstract][Full Text] [Related]
5. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients. Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189 [TBL] [Abstract][Full Text] [Related]
6. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma. Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434 [TBL] [Abstract][Full Text] [Related]
7. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma. Huang QR; Li JW; Pan XB Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227 [TBL] [Abstract][Full Text] [Related]
8. A robust two-gene signature for glioblastoma survival prediction. Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992 [TBL] [Abstract][Full Text] [Related]
9. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749 [TBL] [Abstract][Full Text] [Related]
10. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer. Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477 [TBL] [Abstract][Full Text] [Related]
11. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
12. A 63 signature genes prediction system is effective for glioblastoma prognosis. Zhang Y; Xu J; Zhu X Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370 [TBL] [Abstract][Full Text] [Related]
13. A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients. Hou Z; Yang J; Wang H; Liu D; Zhang H Biomed Res Int; 2019; 2019():9506461. PubMed ID: 31032367 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing. Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341 [TBL] [Abstract][Full Text] [Related]
15. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database. Lei CG; Jia XY; Sun WJ Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982 [TBL] [Abstract][Full Text] [Related]
16. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus. Shukla S; Pia Patric IR; Thinagararjan S; Srinivasan S; Mondal B; Hegde AS; Chandramouli BA; Santosh V; Arivazhagan A; Somasundaram K Cancer Res; 2013 Nov; 73(22):6563-73. PubMed ID: 24078801 [TBL] [Abstract][Full Text] [Related]
17. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma. Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927 [TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of an immune-based prognostic score model in glioblastoma. Qin Z; Zhang X; Chen Z; Liu N Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425 [TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic significance of TCTN1 in human glioblastoma. Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma. Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]